Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

United Therapeutics Corporation UTHR NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
80/100
5/7 Pass
SharesGrow Intrinsic Value
$1,320.25
+128.2%
Analyst Price Target
$579.83
+0.2%
Metric TTM (2025-03 – 2025-12)
Operating Cash Flow $1.56B
Capital Expenditure $-520.5M
Free Cash Flow $1.04B

People Also View

ALNY
ALNY
Alnylam Pharmaceuticals, Inc.
$339.41
+1.92%
 BGNE
BGNE
BeiGene, Ltd.
$184.71
+0.49%
 INCY
INCY
Incyte Corporation
$97.69
+2.24%
 ASND
ASND
Ascendis Pharma A/S
$249.84
+0.52%
 PCVX
PCVX
Vaxcyte, Inc.
$62.76
+1.64%
 BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
 NUVL
NUVL
Nuvalent, Inc.
$105.02
+1.28%
 APLS
APLS
Apellis Pharmaceuticals, Inc.
$40.85
+0.02%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message